Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 78.00
Bid: 77.60
Ask: 78.40
Change: 0.00 (0.00%)
Spread: 0.80 (1.031%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 78.00
GABI Live PriceLast checked at -
GCP Asset Backed Income is an Investment Trust

To generate attractive risk-adjusted returns through growing distributions and modest capital appreciation over the long term by investing in predominantly UK loans.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - GCP Asset Backed Income Fund Ltd

10 Apr 2024 13:48

Form 8.3 - GCP Asset Backed Income Fund Ltd

8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Rathbones Group Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeGCP Asset Backed Income Fund Ltd
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure09/04/2024
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:1p Ord
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:9,576,4372.25%  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:9,576,4372.25%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
1p Ordinary SharesSale3,10667p

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?No

Date of disclosure:10/04/2024
Contact name:Liam Smith – Compliance Department
Telephone number:0151 243 2924

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

Date   Source Headline
10th Sep 20197:00 amRNSHalf-Yearly Report & Financial Statements
2nd Sep 201910:01 amRNSTotal Voting Rights & Additional Listing
22nd Aug 20197:00 amRNSAdditional Listing
8th Aug 20197:00 amRNSScrip Share Reference Price
2nd Aug 20197:00 amRNSInvestor Report as at 30 June 2019
24th Jul 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Jul 20197:00 amRNSNet Asset Value(s)
1st Jul 20194:04 pmRNSChange of Name Administrator and Company Secretary
28th Jun 20197:00 amRNSTotal Voting Rights
27th Jun 201911:47 amRNSHolding(s) in Company
25th Jun 20198:39 amRNSResult of Placing
13th Jun 20194:14 pmRNSNew Directorship Notification
4th Jun 20199:26 amRNSTotal Voting Rights & Additional Listing
24th May 20197:00 amRNSAdditional Listing
23rd May 20191:39 pmRNSProposed Placing of New Ordinary Shares
23rd May 20191:30 pmRNSResult of AGM & EGM
10th May 20192:06 pmRNSScrip Share Reference Price - Replacement
10th May 201912:17 pmRNSScrip Share Reference Price
1st May 20197:00 amRNSInvestor Report as at 31 March 2019
25th Apr 20194:11 pmRNSHolding(s) in Company
24th Apr 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Apr 20197:00 amRNSRevolving Credit Facility
11th Apr 20197:00 amRNSNet Asset Value(s)
10th Apr 20197:00 amRNSNotices of AGM & EGM
29th Mar 20197:00 amRNSAnnual Report & Financial Statements
29th Mar 20197:00 amRNSTotal Voting Rights
15th Mar 20192:57 pmRNSHolding(s) in Company
1st Mar 20199:55 amRNSTotal Voting Rights and Additional Listing
21st Feb 20197:00 amRNSAdditional Listing
7th Feb 20197:00 amRNSScrip Share Reference Price
31st Jan 20197:00 amRNSInvestor Report as at 31 December 2018
29th Jan 20193:54 pmRNSDirector/PDMR Shareholding
23rd Jan 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Jan 20197:00 amRNSPossible Equity Raise
17th Jan 20194:54 pmRNSHolding(s) in Company
17th Jan 20197:00 amRNSNet Asset Value(s)
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 20187:00 amRNSConversion of C Shares
11th Dec 20187:00 amRNSResult of Placing
5th Dec 20187:00 amRNSProposed Placing of Ordinary Shares
30th Nov 20189:25 amRNSTotal Voting Rights & Additional Listing
28th Nov 20187:00 amRNSConversion of C Shares
21st Nov 20187:00 amRNSAdditional Listing
8th Nov 20187:00 amRNSScrip Share Reference Price
1st Nov 20187:00 amRNSInvestor Report as at 30 September 2018
31st Oct 20187:00 amRNSTotal Voting Rights
23rd Oct 20187:00 amRNSDividend Declaration & Scrip Dividend Alternative
15th Oct 20187:00 amRNSNet Asset Value(s)
10th Oct 20182:42 pmRNSTotal Voting Rights
2nd Oct 20183:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.